In cancer cells, G6PD was found to undergo O-GlcNAcylation, where the modification at Ser84 was essential for maintaining the enzyme’s activity, metabolic flux through the PPP, NADPH production, and increased levels of the ROS scavenger glutathione (GSH) [311]. The gene discussed is G6PD; the disease is cancer.